Overall Survival and Durable Responses in Patients WithBRAFV600–Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib

Title
Overall Survival and Durable Responses in Patients WithBRAFV600–Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 34, Issue 8, Pages 871-878
Publisher
American Society of Clinical Oncology (ASCO)
Online
2016-01-26
DOI
10.1200/jco.2015.62.9345

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started